WHO ICTRP trial
A Phase I, open-label trial to investigate pharmacokinetics, safety and…
EUCTR2006-002183-26-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2006-002183-26-GB |
|---|---|
| Public title | A Phase I, open-label trial to investigate pharmacokinetics, safety and tolerability of TMC125 at steady-state in treatment-experienced HIV-1 infected children. |
| Scientific title | A Phase I, open-label trial to investigate pharmacokinetics, safety and tolerability of TMC125 at steady-state in treatment-experienced HIV-1 infected children. |
| Primary sponsor | Tibotec Pharmaceuticals Ltd |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): yes Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Germany;United Kingdom |
| Conditions | HIV-1 MedDRA version: 8.1 Level: LLT Classification code 10020192 Term: HIV-1 |
| Interventions | Product Name: TMC125 Product Code: TMC125 (formulation - F060) Pharmaceutical Form: Tablet CAS Number: 269055-15-4 Current Sponsor code: TMC125 Other descriptive name: R165335, Lab code 094268 Concentration unit: mg milligram(s)… |
| Registration date | Jul 22, 2006 |
| Target size | 40 |
| Secondary IDs | TMC125-C126;2006-002183-26-DE |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: